SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Dart moves up on forming Blue Dart Med-Express Consortium to deliver medical supplies

14 May 2021 Evaluate

Blue Dart Express is currently trading at Rs. 5378.35, up by 29.25 points or 0.55% from its previous closing of Rs. 5349.10 on the BSE.

The scrip opened at Rs. 5399.95 and has touched a high and low of Rs. 5417.65 and Rs. 5340.70 respectively. So far 239 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 5847.95 on 31-Mar-2021 and a 52 week low of Rs. 1860.00 on 17-Aug-2020.

Last one week high and low of the scrip stood at Rs. 5555.00 and Rs. 5275.00 respectively. The current market cap of the company is Rs. 12761.71 crore.

The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 13.28% and 11.72% respectively.

Blue Dart Express and part of the Deutsche Post DHL Group (DPDHL) have formed Blue Dart Med-Express Consortium with the mission of revolutionizing the delivery of vaccines and emergency medical supplies to the remotest parts of India with Drones. Blue Dart Med-Express Consortium is part of the ‘Medicine from the Sky’ project in collaboration with the Government of Telangana, World Economic Forum, Niti Aayog and Healthnet Global.

The Ministry of Civil Aviation (MoCA) has granted the project with necessary exemptions and rights to fly drone flights on an experimental basis in Telangana. The aim is to assess an alternate logistics route in providing safe, accurate and reliable pickup and delivery of health care items (medicines, covid-19 vaccines, units of blood, diagnostic specimens and other lifesaving equipment) from the distribution centre to a specific location and back.

Blue Dart Express, South Asia's premier express air and integrated transportation & distribution company, offers secure and reliable delivery of consignments in India.

Blue Dart Express Share Price

5174.65 128.70 (2.55%)
10-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×